It’s déjà vu all over again as COVID-19 is on the rise across Europe.
It is wrestling with a third wave of the coronavirus pandemic as a number of countries raise concerns over the AstraZeneca vaccine.
The EU, plagued by vaccine delays, is also dealing with concerns that the AstraZeneca vaccine could lead to an increased risk of blood clots – something the company denies.
Nevertheless, Germany, France, Italy and Spain joined with 11 of their neighbors this week to suspend use of the vaccine until the matter could be studied.
Meanwhile, here in the United States, vaccinations are on the rise amid warnings not to become complacent in the race to eradicate the virus.
- Rishi Desai is the chief medical officer for health at Osmosis.org.
- Dr. Xi Chen is an associate professor of public health at Yale University.
- Chris Smith is a Consultant Virologist at the University of Cambridge and the co-presenter of the “Naked Scientists” podcast.
- William Haseltine is the Chair and President of ACCESS Health International and the author of “Variants — The Shape-Shifting Challenge of COVID-19.”
More than 109 million doses of the coronavirus vaccine have been administered in the U.S., reaching 21.4% of the total U.S. population.
The latest data: https://t.co/FDt0jLfQJP
— NPR Politics (@nprpolitics) March 17, 2021
— Reuters World (@ReutersWorld) March 16, 2021
— The Hill (@thehill) March 16, 2021
Optimism is spreading in the U.S. as COVID-19 deaths plummet, states ease restrictions and open vaccinations to younger adults. But health experts say the surge in coronavirus cases in Europe should serve as a warning not to drop safeguards too early. https://t.co/ygQbrVen1L
— The Associated Press (@AP) March 17, 2021